Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for RARG
Z-value: 1.47
Motif logo
Transcription factors associated with RARG
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
RARG
|
ENSG00000172819.12 | retinoic acid receptor gamma |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| RARG | hg19_v2_chr12_-_53625958_53626036 | 0.89 | 3.1e-11 | Click! |
Activity profile of RARG motif
Sorted Z-values of RARG motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_51472222 | 8.90 |
ENST00000376851.3
|
KLK6
|
kallikrein-related peptidase 6 |
| chr3_-_50340996 | 8.79 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
| chr19_-_51466681 | 8.51 |
ENST00000456750.2
|
KLK6
|
kallikrein-related peptidase 6 |
| chr2_-_31637560 | 7.75 |
ENST00000379416.3
|
XDH
|
xanthine dehydrogenase |
| chr19_-_51472031 | 7.73 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr8_-_23261589 | 7.56 |
ENST00000524168.1
ENST00000523833.2 ENST00000519243.1 ENST00000389131.3 |
LOXL2
|
lysyl oxidase-like 2 |
| chr19_-_51487282 | 6.99 |
ENST00000595820.1
ENST00000597707.1 ENST00000336317.4 |
KLK7
|
kallikrein-related peptidase 7 |
| chr2_+_234104079 | 6.62 |
ENST00000417661.1
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
| chr9_+_33795533 | 6.61 |
ENST00000379405.3
|
PRSS3
|
protease, serine, 3 |
| chr19_-_51504852 | 6.19 |
ENST00000391806.2
ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8
|
kallikrein-related peptidase 8 |
| chr1_+_150522222 | 6.15 |
ENST00000369039.5
|
ADAMTSL4
|
ADAMTS-like 4 |
| chr8_-_144651024 | 5.84 |
ENST00000524906.1
ENST00000532862.1 ENST00000534459.1 |
MROH6
|
maestro heat-like repeat family member 6 |
| chr17_+_7942424 | 5.69 |
ENST00000573359.1
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
| chr2_-_31440377 | 5.55 |
ENST00000444918.2
ENST00000403897.3 |
CAPN14
|
calpain 14 |
| chr4_-_111119804 | 5.41 |
ENST00000394607.3
ENST00000302274.3 |
ELOVL6
|
ELOVL fatty acid elongase 6 |
| chr7_-_107642348 | 5.09 |
ENST00000393561.1
|
LAMB1
|
laminin, beta 1 |
| chr19_-_51568324 | 4.85 |
ENST00000595547.1
ENST00000335422.3 ENST00000595793.1 ENST00000596955.1 |
KLK13
|
kallikrein-related peptidase 13 |
| chr15_-_75017711 | 4.82 |
ENST00000567032.1
ENST00000564596.1 ENST00000566503.1 ENST00000395049.4 ENST00000395048.2 ENST00000379727.3 |
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1 |
| chr19_+_54371114 | 4.53 |
ENST00000448420.1
ENST00000439000.1 ENST00000391770.4 ENST00000391771.1 |
MYADM
|
myeloid-associated differentiation marker |
| chr1_-_113498943 | 4.36 |
ENST00000369626.3
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1 |
| chr19_-_51487071 | 4.21 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
| chr5_+_147691979 | 4.06 |
ENST00000274565.4
|
SPINK7
|
serine peptidase inhibitor, Kazal type 7 (putative) |
| chr18_-_21242774 | 4.05 |
ENST00000322980.9
|
ANKRD29
|
ankyrin repeat domain 29 |
| chr1_-_17304771 | 4.04 |
ENST00000375534.3
|
MFAP2
|
microfibrillar-associated protein 2 |
| chr20_+_3776371 | 4.04 |
ENST00000245960.5
|
CDC25B
|
cell division cycle 25B |
| chr1_+_150480576 | 3.92 |
ENST00000346569.6
|
ECM1
|
extracellular matrix protein 1 |
| chr20_+_3776936 | 3.90 |
ENST00000439880.2
|
CDC25B
|
cell division cycle 25B |
| chr12_+_13349650 | 3.89 |
ENST00000256951.5
ENST00000431267.2 ENST00000542474.1 ENST00000544053.1 |
EMP1
|
epithelial membrane protein 1 |
| chr7_+_48128194 | 3.87 |
ENST00000416681.1
ENST00000331803.4 ENST00000432131.1 |
UPP1
|
uridine phosphorylase 1 |
| chr2_+_220492116 | 3.83 |
ENST00000373760.2
|
SLC4A3
|
solute carrier family 4 (anion exchanger), member 3 |
| chr22_+_38071615 | 3.80 |
ENST00000215909.5
|
LGALS1
|
lectin, galactoside-binding, soluble, 1 |
| chr19_+_39616410 | 3.76 |
ENST00000602004.1
ENST00000599470.1 ENST00000321944.4 ENST00000593480.1 ENST00000358301.3 ENST00000593690.1 ENST00000599386.1 |
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4 |
| chr7_+_48128316 | 3.74 |
ENST00000341253.4
|
UPP1
|
uridine phosphorylase 1 |
| chr2_+_228678550 | 3.64 |
ENST00000409189.3
ENST00000358813.4 |
CCL20
|
chemokine (C-C motif) ligand 20 |
| chr17_+_2699697 | 3.64 |
ENST00000254695.8
ENST00000366401.4 ENST00000542807.1 |
RAP1GAP2
|
RAP1 GTPase activating protein 2 |
| chr8_+_86376081 | 3.61 |
ENST00000285379.5
|
CA2
|
carbonic anhydrase II |
| chr15_+_90728145 | 3.56 |
ENST00000561085.1
ENST00000379122.3 ENST00000332496.6 |
SEMA4B
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
| chr15_+_39873268 | 3.45 |
ENST00000397591.2
ENST00000260356.5 |
THBS1
|
thrombospondin 1 |
| chr1_+_15479021 | 3.44 |
ENST00000428417.1
|
TMEM51
|
transmembrane protein 51 |
| chr1_+_15479054 | 3.44 |
ENST00000376014.3
ENST00000451326.2 |
TMEM51
|
transmembrane protein 51 |
| chr10_+_77056134 | 3.43 |
ENST00000528121.1
ENST00000416398.1 |
ZNF503-AS1
|
ZNF503 antisense RNA 1 |
| chr3_-_52569023 | 3.42 |
ENST00000307076.4
|
NT5DC2
|
5'-nucleotidase domain containing 2 |
| chr1_+_45212051 | 3.38 |
ENST00000372222.3
|
KIF2C
|
kinesin family member 2C |
| chr7_+_48128854 | 3.38 |
ENST00000436673.1
ENST00000429491.2 |
UPP1
|
uridine phosphorylase 1 |
| chr15_-_74501360 | 3.30 |
ENST00000323940.5
|
STRA6
|
stimulated by retinoic acid 6 |
| chr11_-_2160180 | 3.27 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr18_-_21242833 | 3.24 |
ENST00000586087.1
ENST00000592179.1 |
ANKRD29
|
ankyrin repeat domain 29 |
| chr5_+_33936491 | 3.22 |
ENST00000330120.3
|
RXFP3
|
relaxin/insulin-like family peptide receptor 3 |
| chr1_+_45212074 | 3.21 |
ENST00000372217.1
|
KIF2C
|
kinesin family member 2C |
| chr15_-_34629922 | 3.21 |
ENST00000559484.1
ENST00000354181.3 ENST00000558589.1 ENST00000458406.2 |
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6 |
| chrX_+_135230712 | 3.14 |
ENST00000535737.1
|
FHL1
|
four and a half LIM domains 1 |
| chr1_+_17575584 | 3.12 |
ENST00000375460.3
|
PADI3
|
peptidyl arginine deiminase, type III |
| chr1_-_150693318 | 3.08 |
ENST00000442853.1
ENST00000368995.4 ENST00000368993.2 ENST00000361824.2 ENST00000322343.7 |
HORMAD1
|
HORMA domain containing 1 |
| chr4_-_159094194 | 3.05 |
ENST00000592057.1
ENST00000585682.1 ENST00000393807.5 |
FAM198B
|
family with sequence similarity 198, member B |
| chrX_+_64887512 | 3.02 |
ENST00000360270.5
|
MSN
|
moesin |
| chr18_+_21529811 | 3.01 |
ENST00000588004.1
|
LAMA3
|
laminin, alpha 3 |
| chr13_-_103046837 | 2.96 |
ENST00000607251.1
|
FGF14-IT1
|
FGF14 intronic transcript 1 (non-protein coding) |
| chr12_-_57634475 | 2.93 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
| chr19_+_676385 | 2.93 |
ENST00000166139.4
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein) |
| chr22_+_23248512 | 2.89 |
ENST00000390325.2
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
| chr19_-_51845378 | 2.88 |
ENST00000335624.4
|
VSIG10L
|
V-set and immunoglobulin domain containing 10 like |
| chr10_-_121296045 | 2.86 |
ENST00000392865.1
|
RGS10
|
regulator of G-protein signaling 10 |
| chr2_+_220491973 | 2.85 |
ENST00000358055.3
|
SLC4A3
|
solute carrier family 4 (anion exchanger), member 3 |
| chr2_-_190044480 | 2.78 |
ENST00000374866.3
|
COL5A2
|
collagen, type V, alpha 2 |
| chr1_+_45205498 | 2.78 |
ENST00000372218.4
|
KIF2C
|
kinesin family member 2C |
| chr21_-_32931290 | 2.76 |
ENST00000286827.3
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1 |
| chr1_-_6479963 | 2.76 |
ENST00000377836.4
ENST00000487437.1 ENST00000489730.1 ENST00000377834.4 |
HES2
|
hes family bHLH transcription factor 2 |
| chr15_+_45406519 | 2.76 |
ENST00000323030.5
|
DUOXA2
|
dual oxidase maturation factor 2 |
| chr1_-_153521597 | 2.75 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
| chr2_-_235405168 | 2.75 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr19_+_6739662 | 2.74 |
ENST00000313285.8
ENST00000313244.9 ENST00000596758.1 |
TRIP10
|
thyroid hormone receptor interactor 10 |
| chr16_+_50300427 | 2.73 |
ENST00000394697.2
ENST00000566433.2 ENST00000538642.1 |
ADCY7
|
adenylate cyclase 7 |
| chr19_-_11689752 | 2.71 |
ENST00000592659.1
ENST00000592828.1 ENST00000218758.5 ENST00000412435.2 |
ACP5
|
acid phosphatase 5, tartrate resistant |
| chr2_-_192016316 | 2.70 |
ENST00000358470.4
ENST00000432798.1 ENST00000450994.1 |
STAT4
|
signal transducer and activator of transcription 4 |
| chr17_+_7942335 | 2.68 |
ENST00000380183.4
ENST00000572022.1 ENST00000380173.2 |
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
| chr20_-_23030296 | 2.64 |
ENST00000377103.2
|
THBD
|
thrombomodulin |
| chr1_-_50489547 | 2.62 |
ENST00000371836.1
ENST00000371839.1 ENST00000371838.1 |
AGBL4
|
ATP/GTP binding protein-like 4 |
| chr15_-_78423567 | 2.57 |
ENST00000561190.1
ENST00000559645.1 ENST00000560618.1 ENST00000559054.1 |
CIB2
|
calcium and integrin binding family member 2 |
| chr15_-_89755034 | 2.54 |
ENST00000563254.1
|
RLBP1
|
retinaldehyde binding protein 1 |
| chr1_-_154946825 | 2.54 |
ENST00000368453.4
ENST00000368450.1 ENST00000366442.2 |
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1 |
| chr20_-_52790512 | 2.52 |
ENST00000216862.3
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1 |
| chr15_-_81616446 | 2.50 |
ENST00000302824.6
|
STARD5
|
StAR-related lipid transfer (START) domain containing 5 |
| chr5_-_149682447 | 2.50 |
ENST00000328668.7
|
ARSI
|
arylsulfatase family, member I |
| chr1_-_20812690 | 2.47 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
| chr11_-_66103932 | 2.45 |
ENST00000311320.4
|
RIN1
|
Ras and Rab interactor 1 |
| chr1_+_152881014 | 2.44 |
ENST00000368764.3
ENST00000392667.2 |
IVL
|
involucrin |
| chr2_-_208031542 | 2.42 |
ENST00000423015.1
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
| chr5_+_162887556 | 2.39 |
ENST00000393915.4
ENST00000432118.2 ENST00000358715.3 |
HMMR
|
hyaluronan-mediated motility receptor (RHAMM) |
| chr3_-_48632593 | 2.38 |
ENST00000454817.1
ENST00000328333.8 |
COL7A1
|
collagen, type VII, alpha 1 |
| chr3_-_48130314 | 2.36 |
ENST00000439356.1
ENST00000395734.3 ENST00000426837.2 |
MAP4
|
microtubule-associated protein 4 |
| chr15_-_34630234 | 2.36 |
ENST00000558667.1
ENST00000561120.1 ENST00000559236.1 ENST00000397702.2 |
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6 |
| chr5_+_137514687 | 2.30 |
ENST00000394894.3
|
KIF20A
|
kinesin family member 20A |
| chr5_+_137514834 | 2.29 |
ENST00000508792.1
ENST00000504621.1 |
KIF20A
|
kinesin family member 20A |
| chr14_+_76776957 | 2.29 |
ENST00000512784.1
|
ESRRB
|
estrogen-related receptor beta |
| chr8_+_70404996 | 2.27 |
ENST00000402687.4
ENST00000419716.3 |
SULF1
|
sulfatase 1 |
| chr22_+_38035459 | 2.27 |
ENST00000357436.4
|
SH3BP1
|
SH3-domain binding protein 1 |
| chr12_+_22778291 | 2.26 |
ENST00000545979.1
|
ETNK1
|
ethanolamine kinase 1 |
| chr1_+_17559776 | 2.25 |
ENST00000537499.1
ENST00000413717.2 ENST00000536552.1 |
PADI1
|
peptidyl arginine deiminase, type I |
| chr11_-_111783595 | 2.22 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
| chr14_+_73706308 | 2.20 |
ENST00000554301.1
ENST00000555445.1 |
PAPLN
|
papilin, proteoglycan-like sulfated glycoprotein |
| chr10_+_17271266 | 2.20 |
ENST00000224237.5
|
VIM
|
vimentin |
| chr22_+_30792980 | 2.19 |
ENST00000403484.1
ENST00000405717.3 ENST00000402592.3 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
| chr19_+_54372639 | 2.19 |
ENST00000391769.2
|
MYADM
|
myeloid-associated differentiation marker |
| chr3_+_38206975 | 2.19 |
ENST00000446845.1
ENST00000311806.3 |
OXSR1
|
oxidative stress responsive 1 |
| chr5_+_150591678 | 2.19 |
ENST00000523466.1
|
GM2A
|
GM2 ganglioside activator |
| chr19_-_43702231 | 2.17 |
ENST00000597374.1
ENST00000599371.1 |
PSG4
|
pregnancy specific beta-1-glycoprotein 4 |
| chr19_-_43032532 | 2.15 |
ENST00000403461.1
ENST00000352591.5 ENST00000358394.3 ENST00000403444.3 ENST00000308072.4 ENST00000599389.1 ENST00000351134.3 ENST00000161559.6 |
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
| chr11_-_119599794 | 2.15 |
ENST00000264025.3
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
| chr9_-_35103105 | 2.14 |
ENST00000452248.2
ENST00000356493.5 |
STOML2
|
stomatin (EPB72)-like 2 |
| chr2_+_192543153 | 2.14 |
ENST00000425611.2
|
NABP1
|
nucleic acid binding protein 1 |
| chr14_-_35183755 | 2.13 |
ENST00000555765.1
|
CFL2
|
cofilin 2 (muscle) |
| chr1_-_153521714 | 2.12 |
ENST00000368713.3
|
S100A3
|
S100 calcium binding protein A3 |
| chr22_-_37915247 | 2.12 |
ENST00000251973.5
|
CARD10
|
caspase recruitment domain family, member 10 |
| chr1_+_155583012 | 2.11 |
ENST00000462250.2
|
MSTO1
|
misato 1, mitochondrial distribution and morphology regulator |
| chr17_-_27503770 | 2.11 |
ENST00000533112.1
|
MYO18A
|
myosin XVIIIA |
| chr1_-_113498616 | 2.09 |
ENST00000433570.4
ENST00000538576.1 ENST00000458229.1 |
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1 |
| chr2_-_165698662 | 2.09 |
ENST00000194871.6
ENST00000445474.2 |
COBLL1
|
cordon-bleu WH2 repeat protein-like 1 |
| chr17_-_76183111 | 2.09 |
ENST00000405273.1
ENST00000590862.1 ENST00000590430.1 ENST00000586613.1 |
TK1
|
thymidine kinase 1, soluble |
| chr2_-_208031943 | 2.07 |
ENST00000421199.1
ENST00000457962.1 |
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
| chr11_-_66496430 | 2.07 |
ENST00000533211.1
|
SPTBN2
|
spectrin, beta, non-erythrocytic 2 |
| chr3_-_196756646 | 2.06 |
ENST00000439320.1
ENST00000296351.4 ENST00000296350.5 |
MFI2
|
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 |
| chr16_-_74734742 | 2.06 |
ENST00000308807.7
ENST00000573267.1 |
MLKL
|
mixed lineage kinase domain-like |
| chr1_-_43855444 | 2.06 |
ENST00000372455.4
|
MED8
|
mediator complex subunit 8 |
| chr12_+_119616447 | 2.05 |
ENST00000281938.2
|
HSPB8
|
heat shock 22kDa protein 8 |
| chr19_+_917287 | 2.04 |
ENST00000592648.1
ENST00000234371.5 |
KISS1R
|
KISS1 receptor |
| chr7_-_76247617 | 2.04 |
ENST00000441393.1
|
POMZP3
|
POM121 and ZP3 fusion |
| chr16_-_2770216 | 2.02 |
ENST00000302641.3
|
PRSS27
|
protease, serine 27 |
| chr12_-_52585765 | 2.01 |
ENST00000313234.5
ENST00000394815.2 |
KRT80
|
keratin 80 |
| chr19_-_46974741 | 2.01 |
ENST00000313683.10
ENST00000602246.1 |
PNMAL1
|
paraneoplastic Ma antigen family-like 1 |
| chr12_-_12674032 | 2.00 |
ENST00000298573.4
|
DUSP16
|
dual specificity phosphatase 16 |
| chr19_-_46974664 | 2.00 |
ENST00000438932.2
|
PNMAL1
|
paraneoplastic Ma antigen family-like 1 |
| chr5_-_147211190 | 1.99 |
ENST00000510027.2
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
| chr15_+_67430339 | 1.98 |
ENST00000439724.3
|
SMAD3
|
SMAD family member 3 |
| chr8_-_125486755 | 1.97 |
ENST00000499418.2
ENST00000530778.1 |
RNF139-AS1
|
RNF139 antisense RNA 1 (head to head) |
| chr2_+_210517895 | 1.97 |
ENST00000447185.1
|
MAP2
|
microtubule-associated protein 2 |
| chr19_+_45281118 | 1.96 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
| chr19_-_1513188 | 1.95 |
ENST00000330475.4
|
ADAMTSL5
|
ADAMTS-like 5 |
| chr12_-_95510743 | 1.95 |
ENST00000551521.1
|
FGD6
|
FYVE, RhoGEF and PH domain containing 6 |
| chr1_+_44401479 | 1.93 |
ENST00000438616.3
|
ARTN
|
artemin |
| chr10_+_17272608 | 1.93 |
ENST00000421459.2
|
VIM
|
vimentin |
| chr10_-_33625154 | 1.91 |
ENST00000265371.4
|
NRP1
|
neuropilin 1 |
| chr9_+_116298778 | 1.91 |
ENST00000462143.1
|
RGS3
|
regulator of G-protein signaling 3 |
| chr14_+_37126765 | 1.90 |
ENST00000402703.2
|
PAX9
|
paired box 9 |
| chr11_-_2170786 | 1.89 |
ENST00000300632.5
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr5_-_60140009 | 1.89 |
ENST00000505959.1
|
ELOVL7
|
ELOVL fatty acid elongase 7 |
| chr19_-_46148820 | 1.89 |
ENST00000587152.1
|
EML2
|
echinoderm microtubule associated protein like 2 |
| chr3_+_12330560 | 1.84 |
ENST00000397026.2
|
PPARG
|
peroxisome proliferator-activated receptor gamma |
| chr19_+_42301079 | 1.84 |
ENST00000596544.1
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3 |
| chr20_+_62492566 | 1.83 |
ENST00000369916.3
|
ABHD16B
|
abhydrolase domain containing 16B |
| chr1_-_152552980 | 1.81 |
ENST00000368787.3
|
LCE3D
|
late cornified envelope 3D |
| chrX_+_99899180 | 1.80 |
ENST00000373004.3
|
SRPX2
|
sushi-repeat containing protein, X-linked 2 |
| chr6_-_160148356 | 1.79 |
ENST00000401980.3
ENST00000545162.1 |
SOD2
|
superoxide dismutase 2, mitochondrial |
| chr10_+_11784360 | 1.79 |
ENST00000379215.4
ENST00000420401.1 |
ECHDC3
|
enoyl CoA hydratase domain containing 3 |
| chr15_-_78423863 | 1.78 |
ENST00000539011.1
|
CIB2
|
calcium and integrin binding family member 2 |
| chr3_-_139258521 | 1.78 |
ENST00000483943.2
ENST00000232219.2 ENST00000492918.1 |
RBP1
|
retinol binding protein 1, cellular |
| chr12_-_48152611 | 1.77 |
ENST00000389212.3
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
| chr19_+_2389784 | 1.76 |
ENST00000332578.3
|
TMPRSS9
|
transmembrane protease, serine 9 |
| chr12_-_109219937 | 1.76 |
ENST00000546697.1
|
SSH1
|
slingshot protein phosphatase 1 |
| chr9_+_74526384 | 1.75 |
ENST00000334731.2
ENST00000377031.3 |
C9orf85
|
chromosome 9 open reading frame 85 |
| chr8_-_21999447 | 1.75 |
ENST00000306306.3
ENST00000521744.1 |
REEP4
|
receptor accessory protein 4 |
| chr8_-_125740514 | 1.75 |
ENST00000325064.5
ENST00000518547.1 |
MTSS1
|
metastasis suppressor 1 |
| chr9_+_36572851 | 1.75 |
ENST00000298048.2
ENST00000538311.1 ENST00000536987.1 ENST00000545008.1 ENST00000536860.1 ENST00000536329.1 ENST00000541717.1 ENST00000543751.1 |
MELK
|
maternal embryonic leucine zipper kinase |
| chr12_-_8814669 | 1.75 |
ENST00000535411.1
ENST00000540087.1 |
MFAP5
|
microfibrillar associated protein 5 |
| chr9_-_35685452 | 1.74 |
ENST00000607559.1
|
TPM2
|
tropomyosin 2 (beta) |
| chr10_-_75634219 | 1.73 |
ENST00000305762.7
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
| chr5_-_147211226 | 1.73 |
ENST00000296695.5
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
| chr11_+_57365150 | 1.72 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
| chr19_+_16308659 | 1.71 |
ENST00000590263.1
ENST00000590756.1 ENST00000541844.1 |
AP1M1
|
adaptor-related protein complex 1, mu 1 subunit |
| chr8_-_21999362 | 1.69 |
ENST00000334530.5
ENST00000518664.1 |
REEP4
|
receptor accessory protein 4 |
| chr19_+_1407733 | 1.68 |
ENST00000592453.1
|
DAZAP1
|
DAZ associated protein 1 |
| chr11_+_35198243 | 1.68 |
ENST00000528455.1
|
CD44
|
CD44 molecule (Indian blood group) |
| chr10_+_54074033 | 1.67 |
ENST00000373970.3
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1 |
| chrX_-_132095419 | 1.65 |
ENST00000370836.2
ENST00000521489.1 |
HS6ST2
|
heparan sulfate 6-O-sulfotransferase 2 |
| chr22_-_38699003 | 1.65 |
ENST00000451964.1
|
CSNK1E
|
casein kinase 1, epsilon |
| chr15_-_64673630 | 1.64 |
ENST00000558008.1
ENST00000559519.1 ENST00000380258.2 |
KIAA0101
|
KIAA0101 |
| chr17_+_7905912 | 1.64 |
ENST00000254854.4
|
GUCY2D
|
guanylate cyclase 2D, membrane (retina-specific) |
| chr19_+_19639670 | 1.63 |
ENST00000436027.5
|
YJEFN3
|
YjeF N-terminal domain containing 3 |
| chr1_+_119957554 | 1.63 |
ENST00000543831.1
ENST00000433745.1 ENST00000369416.3 |
HSD3B2
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
| chr11_-_62752162 | 1.62 |
ENST00000458333.2
ENST00000421062.2 |
SLC22A6
|
solute carrier family 22 (organic anion transporter), member 6 |
| chr14_-_102976135 | 1.61 |
ENST00000560748.1
|
ANKRD9
|
ankyrin repeat domain 9 |
| chr11_-_66103867 | 1.60 |
ENST00000424433.2
|
RIN1
|
Ras and Rab interactor 1 |
| chr19_+_16187085 | 1.60 |
ENST00000300933.4
|
TPM4
|
tropomyosin 4 |
| chr1_-_111991850 | 1.60 |
ENST00000411751.2
|
WDR77
|
WD repeat domain 77 |
| chr17_-_43209862 | 1.59 |
ENST00000322765.5
|
PLCD3
|
phospholipase C, delta 3 |
| chr16_+_8814563 | 1.59 |
ENST00000425191.2
ENST00000569156.1 |
ABAT
|
4-aminobutyrate aminotransferase |
| chr17_+_73750699 | 1.59 |
ENST00000584939.1
|
ITGB4
|
integrin, beta 4 |
| chr5_-_112630598 | 1.58 |
ENST00000302475.4
|
MCC
|
mutated in colorectal cancers |
| chr10_-_75634260 | 1.58 |
ENST00000372765.1
ENST00000351293.3 |
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
| chr6_+_30594619 | 1.57 |
ENST00000318999.7
ENST00000376485.4 ENST00000376478.2 ENST00000319027.5 ENST00000376483.4 ENST00000329992.8 ENST00000330083.5 |
ATAT1
|
alpha tubulin acetyltransferase 1 |
| chr10_-_76995675 | 1.55 |
ENST00000469299.1
|
COMTD1
|
catechol-O-methyltransferase domain containing 1 |
| chr1_-_150849047 | 1.55 |
ENST00000354396.2
ENST00000505755.1 |
ARNT
|
aryl hydrocarbon receptor nuclear translocator |
| chr19_-_4535233 | 1.55 |
ENST00000381848.3
ENST00000588887.1 ENST00000586133.1 |
PLIN5
|
perilipin 5 |
| chr20_+_35973080 | 1.55 |
ENST00000445403.1
|
SRC
|
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog |
| chr4_+_2814011 | 1.55 |
ENST00000502260.1
ENST00000435136.2 |
SH3BP2
|
SH3-domain binding protein 2 |
| chr1_+_70876891 | 1.55 |
ENST00000411986.2
|
CTH
|
cystathionase (cystathionine gamma-lyase) |
| chr17_-_8055747 | 1.54 |
ENST00000317276.4
ENST00000581703.1 |
PER1
|
period circadian clock 1 |
| chrX_+_38420783 | 1.54 |
ENST00000422612.2
ENST00000286824.6 ENST00000545599.1 |
TSPAN7
|
tetraspanin 7 |
| chr20_+_37209820 | 1.53 |
ENST00000537425.1
ENST00000373348.3 ENST00000416116.1 |
ADIG
|
adipogenin |
| chr17_+_1958388 | 1.52 |
ENST00000399849.3
|
HIC1
|
hypermethylated in cancer 1 |
| chr22_+_23243156 | 1.51 |
ENST00000390323.2
|
IGLC2
|
immunoglobulin lambda constant 2 (Kern-Oz- marker) |
Network of associatons between targets according to the STRING database.
First level regulatory network of RARG
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.7 | 11.0 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 2.2 | 6.6 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 2.2 | 8.8 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 2.2 | 6.5 | GO:0015728 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 1.9 | 7.7 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 1.9 | 11.2 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 1.7 | 6.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 1.6 | 4.8 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) cellular alkene metabolic process(GO:0043449) |
| 1.3 | 3.9 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 1.3 | 5.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 1.2 | 3.6 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 1.2 | 3.6 | GO:0042938 | dipeptide transport(GO:0042938) |
| 1.2 | 8.4 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 1.2 | 26.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 1.1 | 5.6 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 1.1 | 5.4 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 1.1 | 1.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 1.0 | 3.1 | GO:0051598 | meiotic DNA double-strand break formation(GO:0042138) meiotic recombination checkpoint(GO:0051598) |
| 0.9 | 9.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.9 | 2.8 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.9 | 2.7 | GO:0097254 | renal tubular secretion(GO:0097254) |
| 0.8 | 2.5 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.8 | 1.7 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
| 0.8 | 2.4 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.8 | 7.3 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.8 | 2.4 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
| 0.8 | 4.0 | GO:0003070 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.8 | 2.4 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.8 | 7.8 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.8 | 6.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.8 | 2.3 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.8 | 3.8 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.8 | 3.8 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.7 | 2.2 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.7 | 2.2 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.7 | 2.2 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.7 | 2.1 | GO:0043318 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) insulin catabolic process(GO:1901143) |
| 0.7 | 2.1 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.7 | 2.1 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.7 | 2.1 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.7 | 7.6 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.7 | 2.7 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.7 | 5.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.6 | 3.1 | GO:0097021 | Peyer's patch morphogenesis(GO:0061146) lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.6 | 3.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.6 | 5.5 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.6 | 5.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.6 | 2.3 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.6 | 1.1 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.5 | 2.2 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.5 | 2.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.5 | 4.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.5 | 2.6 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.5 | 2.1 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.5 | 6.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.5 | 1.0 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.5 | 1.0 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.5 | 3.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.5 | 0.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.5 | 3.0 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
| 0.5 | 1.5 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.5 | 2.8 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.5 | 1.4 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.5 | 2.8 | GO:0030805 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
| 0.5 | 1.9 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.5 | 2.8 | GO:0030421 | defecation(GO:0030421) |
| 0.5 | 1.8 | GO:1901558 | response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.4 | 1.3 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.4 | 2.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
| 0.4 | 3.1 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.4 | 2.6 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.4 | 2.1 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.4 | 0.4 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.4 | 1.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.4 | 1.2 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) fast-twitch skeletal muscle fiber contraction(GO:0031443) relaxation of skeletal muscle(GO:0090076) |
| 0.4 | 1.6 | GO:1904450 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.4 | 2.0 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 0.4 | 2.4 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.4 | 2.3 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.4 | 1.2 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.4 | 1.9 | GO:0060301 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.4 | 1.1 | GO:0021586 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.4 | 5.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.4 | 1.1 | GO:0060435 | bronchiole development(GO:0060435) |
| 0.4 | 3.3 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.4 | 1.8 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.4 | 1.8 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.3 | 2.4 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
| 0.3 | 2.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.3 | 1.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.3 | 4.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.3 | 3.0 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
| 0.3 | 1.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.3 | 1.3 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.3 | 2.2 | GO:0070305 | response to cGMP(GO:0070305) |
| 0.3 | 0.9 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.3 | 0.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.3 | 1.2 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.3 | 1.5 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.3 | 3.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.3 | 1.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.3 | 3.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.3 | 2.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.3 | 0.8 | GO:0000494 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.3 | 6.9 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.3 | 1.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.3 | 1.0 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.3 | 1.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.3 | 1.0 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.2 | 1.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.2 | 0.7 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.2 | 3.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 | 1.5 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.2 | 2.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.2 | 3.4 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.2 | 3.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 | 1.2 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.2 | 4.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.2 | 1.0 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.2 | 0.7 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 0.2 | 0.7 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.2 | 3.8 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.2 | 6.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.2 | 0.7 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.2 | 0.7 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.2 | 3.5 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 | 0.2 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.2 | 0.5 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.2 | 0.9 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
| 0.2 | 1.2 | GO:1902164 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.2 | 0.9 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.2 | 2.5 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.2 | 1.1 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.2 | 1.4 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 0.2 | 1.1 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.2 | 0.9 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.2 | 4.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.2 | 1.5 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.2 | 0.7 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 0.2 | 0.2 | GO:0007431 | salivary gland development(GO:0007431) salivary gland morphogenesis(GO:0007435) branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.2 | 0.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.2 | 1.5 | GO:1903764 | cortical microtubule organization(GO:0043622) regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.2 | 0.6 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
| 0.2 | 0.4 | GO:0048627 | myoblast development(GO:0048627) |
| 0.2 | 0.4 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 0.2 | 1.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.2 | 6.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.2 | 1.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.2 | 4.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.2 | 1.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.2 | 0.6 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.2 | 0.6 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 0.2 | 1.6 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.2 | 0.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.2 | 4.6 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.2 | 1.0 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.2 | 0.8 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 0.2 | 1.0 | GO:0002858 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
| 0.2 | 4.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.2 | 0.6 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.2 | 0.6 | GO:0035054 | septum secundum development(GO:0003285) embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.2 | 1.1 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.2 | 0.4 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.2 | 2.7 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.2 | 0.7 | GO:0019542 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.2 | 0.9 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.2 | 0.4 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.2 | 0.7 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.2 | 4.4 | GO:2000404 | regulation of T cell migration(GO:2000404) |
| 0.2 | 1.1 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.2 | 1.0 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 | 0.7 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.2 | 1.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 | 0.5 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 0.2 | 2.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.2 | 1.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.2 | 0.2 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
| 0.2 | 0.5 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.2 | 0.5 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
| 0.2 | 1.7 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.2 | 1.0 | GO:1903352 | L-ornithine transmembrane transport(GO:1903352) |
| 0.2 | 0.3 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.2 | 1.8 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.2 | 0.7 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.2 | 0.2 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.2 | 0.8 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 | 0.5 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
| 0.2 | 1.8 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.2 | 1.0 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.2 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.2 | 1.8 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.2 | 2.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.2 | 0.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
| 0.2 | 0.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.2 | 6.4 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.2 | 0.5 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.2 | 0.6 | GO:0016071 | mRNA metabolic process(GO:0016071) |
| 0.2 | 2.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 | 0.8 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.2 | 0.5 | GO:0050894 | determination of affect(GO:0050894) |
| 0.2 | 3.9 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.2 | 0.8 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 | 1.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.2 | 0.5 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.2 | 3.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.2 | 1.1 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 0.2 | 0.5 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 0.2 | 1.8 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 0.6 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.1 | 0.6 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.1 | 1.3 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.1 | 0.9 | GO:0014028 | notochord formation(GO:0014028) |
| 0.1 | 1.7 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.1 | 0.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.1 | 0.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 | 0.6 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.1 | 0.4 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.1 | 2.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 | 1.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 | 1.1 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.1 | 0.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.1 | 0.4 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.1 | 2.1 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.1 | 0.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.1 | 0.8 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 | 1.3 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
| 0.1 | 0.4 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.1 | 0.8 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 0.1 | 0.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.1 | 0.6 | GO:0035106 | operant conditioning(GO:0035106) |
| 0.1 | 2.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 | 0.3 | GO:0035669 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.1 | 1.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.1 | 0.5 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.1 | 1.6 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 | 1.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 | 6.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.1 | 0.2 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
| 0.1 | 1.2 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.1 | 0.9 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.1 | 0.5 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
| 0.1 | 2.0 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.1 | 0.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 1.9 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 | 0.1 | GO:0003289 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
| 0.1 | 2.4 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.1 | 9.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.1 | 3.5 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.1 | 1.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.1 | 0.5 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.1 | 0.7 | GO:0006875 | cellular metal ion homeostasis(GO:0006875) |
| 0.1 | 0.6 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.1 | 1.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.1 | 0.9 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.1 | 1.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 | 0.3 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.1 | 0.3 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.1 | 1.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.1 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 | 1.7 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.1 | 1.3 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.1 | 1.4 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 0.9 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.1 | 0.5 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 | 1.5 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.1 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.1 | 0.4 | GO:0009447 | putrescine catabolic process(GO:0009447) |
| 0.1 | 0.3 | GO:0035570 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.1 | 0.8 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.1 | 1.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 | 3.4 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 | 0.6 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.1 | 1.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.1 | 0.9 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 | 0.2 | GO:1901727 | positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
| 0.1 | 0.6 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.1 | 1.0 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.1 | 0.6 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.1 | 0.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.1 | 0.5 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 0.1 | 1.2 | GO:0030220 | platelet formation(GO:0030220) |
| 0.1 | 0.9 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.1 | 0.3 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.1 | 1.6 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 | 0.5 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
| 0.1 | 0.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 2.3 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
| 0.1 | 0.1 | GO:0072069 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 0.1 | 0.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.1 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.1 | 1.6 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 | 1.1 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 | 0.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.1 | 0.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 0.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 0.1 | 1.4 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 | 2.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 | 1.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 1.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 0.8 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 | 0.3 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
| 0.1 | 0.5 | GO:0006939 | smooth muscle contraction(GO:0006939) |
| 0.1 | 1.6 | GO:0021542 | dentate gyrus development(GO:0021542) |
| 0.1 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.1 | 2.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.1 | 0.4 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.1 | 0.5 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 0.1 | 0.8 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.1 | 1.7 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 | 0.4 | GO:1904073 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
| 0.1 | 0.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.1 | 1.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.1 | 0.2 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.1 | 0.5 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 | 0.5 | GO:0045471 | response to ethanol(GO:0045471) |
| 0.1 | 0.4 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.1 | 2.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.1 | 0.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 | 0.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.1 | 1.7 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 | 0.2 | GO:0035993 | subthalamic nucleus development(GO:0021763) deltoid tuberosity development(GO:0035993) prolactin secreting cell differentiation(GO:0060127) superior vena cava morphogenesis(GO:0060578) |
| 0.1 | 0.4 | GO:0032425 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
| 0.1 | 0.6 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.1 | 1.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.1 | 0.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.1 | 0.9 | GO:0030238 | male sex determination(GO:0030238) |
| 0.1 | 0.4 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.1 | 0.5 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.1 | 0.1 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
| 0.1 | 0.4 | GO:0017157 | regulation of exocytosis(GO:0017157) |
| 0.1 | 0.6 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.1 | 0.7 | GO:0046546 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.1 | 0.7 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) negative regulation of myoblast fusion(GO:1901740) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.1 | 0.6 | GO:0060750 | antral ovarian follicle growth(GO:0001547) epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
| 0.1 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.1 | 1.7 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.1 | 0.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.1 | 0.2 | GO:1904346 | positive regulation of growth rate(GO:0040010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
| 0.1 | 0.6 | GO:1902749 | regulation of cell cycle G2/M phase transition(GO:1902749) |
| 0.1 | 1.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 8.9 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 0.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 | 1.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.1 | GO:0021539 | subthalamus development(GO:0021539) |
| 0.1 | 0.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.1 | 0.3 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.1 | 0.8 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.1 | 1.4 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 0.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.1 | 0.4 | GO:0060992 | response to fungicide(GO:0060992) |
| 0.1 | 0.9 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.1 | 0.3 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.1 | 0.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 0.1 | 0.3 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.1 | 1.7 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.1 | 2.8 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.1 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.1 | 0.5 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.1 | 0.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 | 0.5 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.1 | 2.2 | GO:0060996 | dendritic spine development(GO:0060996) |
| 0.1 | 2.3 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 0.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.1 | 0.4 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 | 1.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 | 0.3 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.1 | 0.8 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 | 0.2 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.1 | 0.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.1 | 1.4 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.1 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 0.5 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.1 | 0.6 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 | 0.9 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.1 | 0.6 | GO:0015886 | heme transport(GO:0015886) |
| 0.1 | 1.8 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.1 | 0.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.1 | 0.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 | 0.2 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.1 | 0.2 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
| 0.1 | 0.2 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.1 | 2.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 0.5 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.1 | 0.8 | GO:0017085 | response to insecticide(GO:0017085) |
| 0.1 | 0.4 | GO:0051715 | cytolysis in other organism(GO:0051715) |
| 0.1 | 0.3 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.1 | 0.5 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 0.1 | 0.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.1 | 0.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.1 | 0.4 | GO:0043586 | tongue development(GO:0043586) |
| 0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.1 | 0.6 | GO:0000187 | activation of MAPK activity(GO:0000187) |
| 0.1 | 0.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 | 1.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 0.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 | 1.0 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.1 | 0.6 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 | 1.0 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
| 0.1 | 0.5 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 0.1 | 0.2 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 0.1 | 0.8 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.1 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 1.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 | 0.4 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.1 | 0.8 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 | 0.5 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 | 2.9 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.1 | 1.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 | 0.6 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.0 | 1.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 3.1 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.0 | 3.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
| 0.0 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.0 | 1.0 | GO:0030728 | ovulation(GO:0030728) |
| 0.0 | 0.6 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.0 | 0.4 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.0 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.0 | 0.1 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.0 | 0.1 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.0 | 0.0 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.0 | 0.1 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
| 0.0 | 0.6 | GO:0006275 | regulation of DNA replication(GO:0006275) |
| 0.0 | 1.1 | GO:0032094 | response to food(GO:0032094) |
| 0.0 | 0.3 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.0 | 0.8 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.0 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 | 1.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.0 | 0.3 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.0 | 0.5 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.0 | 0.3 | GO:1901881 | positive regulation of protein complex disassembly(GO:0043243) positive regulation of protein depolymerization(GO:1901881) |
| 0.0 | 0.3 | GO:0042476 | odontogenesis(GO:0042476) |
| 0.0 | 0.2 | GO:0007320 | insemination(GO:0007320) |
| 0.0 | 0.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.0 | 1.5 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 | 0.7 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.0 | 0.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.0 | 0.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.0 | 0.5 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.0 | 1.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 | 0.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.0 | 0.3 | GO:0035898 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.0 | 0.3 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.0 | 0.3 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
| 0.0 | 0.5 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
| 0.0 | 5.7 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
| 0.0 | 0.1 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
| 0.0 | 0.2 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.0 | 1.2 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.0 | 0.4 | GO:0033622 | integrin activation(GO:0033622) |
| 0.0 | 1.4 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.0 | 0.3 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.0 | 0.7 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.0 | 0.4 | GO:0050777 | negative regulation of immune response(GO:0050777) |
| 0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.0 | 0.4 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.0 | 2.8 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 | 0.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 | 0.1 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
| 0.0 | 0.7 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 | 0.2 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 | 0.2 | GO:0060754 | regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.0 | 0.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 | 0.2 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.0 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.0 | 0.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.0 | 0.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.0 | 0.2 | GO:0003014 | renal system process(GO:0003014) |
| 0.0 | 0.5 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.0 | 0.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.0 | 0.2 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.0 | 0.1 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.0 | 3.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 1.3 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.0 | 0.1 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.0 | 0.2 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.0 | 0.4 | GO:0072678 | T cell migration(GO:0072678) |
| 0.0 | 0.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 | 0.4 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 0.0 | 0.2 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.0 | 0.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.0 | 0.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.0 | 1.9 | GO:0031424 | keratinization(GO:0031424) |
| 0.0 | 0.2 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.0 | 0.8 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.0 | 0.2 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.0 | 1.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
| 0.0 | 0.9 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.0 | 0.8 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 | 0.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.0 | 0.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.0 | 1.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.0 | 1.2 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.0 | 0.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.0 | 0.1 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
| 0.0 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.0 | 2.5 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.0 | 0.7 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
| 0.0 | 0.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.0 | 0.1 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) oxidative stress-induced premature senescence(GO:0090403) |
| 0.0 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.0 | 0.3 | GO:0045926 | negative regulation of growth(GO:0045926) |
| 0.0 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
| 0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 | 1.2 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 | 1.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.0 | 0.1 | GO:0019474 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.0 | 0.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.0 | 0.2 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.0 | 0.6 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.0 | 0.8 | GO:0003091 | renal water homeostasis(GO:0003091) |
| 0.0 | 0.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.0 | 0.6 | GO:0097435 | fibril organization(GO:0097435) |
| 0.0 | 0.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 | 0.4 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.0 | 0.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 0.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.0 | 0.7 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.0 | 0.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.0 | 0.2 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.0 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.0 | 0.2 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.0 | 0.4 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 | 0.2 | GO:0060070 | canonical Wnt signaling pathway(GO:0060070) |
| 0.0 | 0.3 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.0 | 0.0 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 0.0 | 0.1 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.0 | 2.2 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.0 | 0.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.0 | 0.3 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.0 | 0.4 | GO:0042220 | response to cocaine(GO:0042220) |
| 0.0 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.0 | 0.2 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.0 | 0.1 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
| 0.0 | 0.2 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.0 | 0.3 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.0 | 0.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.0 | 0.2 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.0 | 0.3 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
| 0.0 | 0.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 | 0.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 | 1.1 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
| 0.0 | 0.2 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.0 | 0.5 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.0 | 0.1 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 | 0.1 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.0 | 0.0 | GO:0021782 | glial cell development(GO:0021782) |
| 0.0 | 0.7 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.0 | 0.1 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.0 | 0.4 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.0 | 0.1 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 0.0 | 0.1 | GO:0032418 | lysosome localization(GO:0032418) |
| 0.0 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.0 | 0.3 | GO:0046039 | GTP metabolic process(GO:0046039) |
| 0.0 | 0.1 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.0 | 0.1 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.0 | 0.2 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 | 0.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.0 | 0.4 | GO:0001881 | receptor recycling(GO:0001881) |
| 0.0 | 0.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.0 | 0.3 | GO:0065009 | regulation of molecular function(GO:0065009) |
| 0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.0 | 0.2 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
| 0.0 | 0.1 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.0 | 0.6 | GO:0019835 | cytolysis(GO:0019835) |
| 0.0 | 0.2 | GO:0034033 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.0 | 0.9 | GO:0002456 | T cell mediated immunity(GO:0002456) |
| 0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 | 0.5 | GO:0008038 | neuron recognition(GO:0008038) |
| 0.0 | 0.0 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.0 | 0.5 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
| 0.0 | 0.2 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.0 | 0.3 | GO:0051291 | protein heterooligomerization(GO:0051291) |
| 0.0 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.0 | 0.7 | GO:0046847 | filopodium assembly(GO:0046847) |
| 0.0 | 0.3 | GO:0016236 | macroautophagy(GO:0016236) |
| 0.0 | 0.4 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
| 0.0 | 0.1 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.0 | 0.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 | 0.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.0 | 0.5 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
| 0.0 | 0.4 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
| 0.0 | 0.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 | 0.0 | GO:0002634 | regulation of germinal center formation(GO:0002634) positive regulation of germinal center formation(GO:0002636) B cell costimulation(GO:0031296) |
| 0.0 | 0.5 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.0 | 0.2 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 0.0 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 0.0 | 0.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.0 | 0.2 | GO:0006625 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.0 | 0.1 | GO:0001556 | oocyte maturation(GO:0001556) |
| 0.0 | 0.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.0 | 0.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.0 | 0.6 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.0 | 0.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 | 0.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 | 0.6 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
| 0.0 | 0.5 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.0 | 0.3 | GO:0097192 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
| 0.0 | 0.3 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.0 | 0.6 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.0 | 0.2 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.0 | 0.2 | GO:0033198 | response to ATP(GO:0033198) |
| 0.0 | 0.3 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
| 0.0 | 0.3 | GO:0043368 | positive T cell selection(GO:0043368) |
| 0.0 | 0.5 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
| 0.0 | 0.2 | GO:0046688 | response to copper ion(GO:0046688) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.1 | GO:0005607 | laminin-2 complex(GO:0005607) |
| 1.6 | 11.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 1.1 | 6.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 0.9 | 2.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.9 | 5.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.7 | 2.6 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.6 | 3.2 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.5 | 2.2 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.5 | 2.0 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.4 | 3.1 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.4 | 2.1 | GO:0032449 | CBM complex(GO:0032449) |
| 0.4 | 2.0 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.4 | 1.6 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.4 | 1.2 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.4 | 3.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.3 | 8.2 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.3 | 4.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.3 | 0.9 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.3 | 2.6 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.3 | 5.5 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.3 | 1.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.3 | 2.9 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.3 | 9.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.2 | 2.0 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.2 | 1.5 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.2 | 6.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.2 | 4.2 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.2 | 1.6 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.2 | 5.3 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.2 | 3.8 | GO:0034709 | methylosome(GO:0034709) |
| 0.2 | 3.8 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.2 | 1.6 | GO:0031415 | NatA complex(GO:0031415) |
| 0.2 | 1.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.2 | 2.3 | GO:0032039 | integrator complex(GO:0032039) |
| 0.2 | 0.6 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.2 | 2.8 | GO:0045180 | basal cortex(GO:0045180) |
| 0.2 | 2.4 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.2 | 0.7 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.2 | 0.9 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.2 | 2.5 | GO:0044297 | cell body(GO:0044297) |
| 0.2 | 1.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.2 | 2.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.2 | 0.8 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.2 | 0.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.2 | 1.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.2 | 1.2 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.2 | 13.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.2 | 0.5 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
| 0.2 | 3.2 | GO:0001726 | ruffle(GO:0001726) |
| 0.1 | 0.7 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.1 | 1.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 0.6 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.1 | 3.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 2.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.1 | 1.7 | GO:0043219 | lateral loop(GO:0043219) |
| 0.1 | 2.0 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 0.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.1 | 0.8 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.1 | 4.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.1 | 2.1 | GO:0008091 | spectrin(GO:0008091) |
| 0.1 | 1.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 1.5 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.1 | 0.5 | GO:0031417 | NatC complex(GO:0031417) |
| 0.1 | 1.2 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.1 | 1.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.1 | 0.4 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.1 | 0.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 0.1 | 9.8 | GO:0005604 | basement membrane(GO:0005604) |
| 0.1 | 2.8 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 1.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.1 | 0.3 | GO:0035841 | new growing cell tip(GO:0035841) |
| 0.1 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.1 | 1.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 2.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 0.4 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.1 | 0.8 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.1 | 1.1 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.1 | 0.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.1 | 2.3 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 0.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 11.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.1 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.1 | 0.9 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.1 | 7.1 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 3.7 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 0.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.1 | 1.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.1 | 8.4 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 1.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 0.6 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.1 | 4.2 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.1 | 0.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 3.8 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.1 | 0.2 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 0.1 | 6.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 1.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.1 | 2.4 | GO:0043034 | costamere(GO:0043034) |
| 0.1 | 1.1 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 1.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.1 | 0.6 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 0.1 | 11.0 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.1 | 2.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.1 | 4.3 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.1 | 1.7 | GO:0031672 | A band(GO:0031672) |
| 0.1 | 1.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.1 | 0.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.1 | 6.5 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.1 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
| 0.1 | 0.6 | GO:0000796 | condensin complex(GO:0000796) |
| 0.1 | 2.1 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 1.1 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.1 | 1.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.1 | 0.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.1 | 0.3 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.1 | 5.8 | GO:0016459 | myosin complex(GO:0016459) |
| 0.1 | 5.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 0.6 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.1 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.1 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.1 | 1.7 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 2.4 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 0.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 0.9 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.1 | 3.7 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.1 | 4.7 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 1.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 0.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.0 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
| 0.0 | 1.5 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.0 | 2.8 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.0 | 0.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.0 | 0.1 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.0 | 3.0 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 5.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.0 | 0.8 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
| 0.0 | 0.9 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.0 | 0.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 3.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.0 | 0.3 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.0 | 13.7 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.0 | 0.3 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.0 | 0.1 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.0 | 0.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.0 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.0 | 12.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 0.6 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.0 | 0.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.0 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 0.5 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.0 | 0.9 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 0.6 | GO:0042555 | MCM complex(GO:0042555) |
| 0.0 | 0.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.0 | 0.1 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.0 | 0.1 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.0 | 1.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.0 | 0.4 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.0 | 0.6 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.0 | 0.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.0 | 5.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.0 | 0.3 | GO:1990234 | transferase complex(GO:1990234) |
| 0.0 | 0.1 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 0.0 | 0.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.0 | 1.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.0 | 0.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.0 | 0.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.0 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.0 | 3.7 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 9.5 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.0 | 0.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 3.9 | GO:0000922 | spindle pole(GO:0000922) |
| 0.0 | 0.4 | GO:0030133 | transport vesicle(GO:0030133) |
| 0.0 | 0.2 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.0 | 4.5 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.0 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.0 | 0.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.0 | 2.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 12.5 | GO:0030141 | secretory granule(GO:0030141) |
| 0.0 | 2.7 | GO:0030018 | Z disc(GO:0030018) |
| 0.0 | 0.3 | GO:0046930 | pore complex(GO:0046930) |
| 0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.0 | 0.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.0 | 0.7 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.0 | 0.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 0.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.0 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 0.1 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 0.2 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.0 | 0.4 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.0 | 3.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.0 | 0.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
| 0.0 | 0.4 | GO:0015629 | actin cytoskeleton(GO:0015629) |
| 0.0 | 0.3 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.0 | 0.1 | GO:0043292 | contractile fiber(GO:0043292) |
| 0.0 | 0.2 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.0 | 1.5 | GO:0005814 | centriole(GO:0005814) |
| 0.0 | 2.0 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.0 | 7.7 | GO:0005912 | adherens junction(GO:0005912) |
| 0.0 | 0.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 2.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 3.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 0.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
| 0.0 | 0.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 0.8 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.0 | 0.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.0 | 0.9 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.0 | 0.5 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.1 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 0.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.0 | 0.1 | GO:0005769 | early endosome(GO:0005769) |
| 0.0 | 0.6 | GO:0030496 | midbody(GO:0030496) |
| 0.0 | 0.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 0.7 | GO:0031410 | cytoplasmic vesicle(GO:0031410) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.8 | 8.4 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 2.5 | 9.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 2.2 | 11.0 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 2.2 | 6.5 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 1.5 | 7.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 1.3 | 6.4 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 1.2 | 3.6 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 1.2 | 3.5 | GO:0070052 | collagen V binding(GO:0070052) |
| 1.1 | 6.6 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 1.1 | 5.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 1.0 | 3.1 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.9 | 3.8 | GO:0030395 | lactose binding(GO:0030395) |
| 0.9 | 9.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.9 | 7.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.8 | 2.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.8 | 3.3 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.8 | 7.3 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.8 | 5.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.7 | 2.1 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.6 | 3.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.6 | 1.8 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.6 | 3.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.6 | 4.1 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.6 | 1.7 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.5 | 2.2 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.5 | 5.7 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.5 | 3.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.5 | 1.4 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 0.5 | 1.4 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 0.5 | 4.3 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.5 | 1.9 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.5 | 3.6 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.4 | 2.6 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 0.4 | 1.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.4 | 1.6 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.4 | 2.0 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.4 | 1.2 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.4 | 1.1 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.4 | 2.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.4 | 1.1 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.4 | 3.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.4 | 1.5 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.4 | 1.1 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.4 | 1.5 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 0.4 | 1.5 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 0.4 | 2.5 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.3 | 1.0 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 0.3 | 1.0 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.3 | 1.0 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.3 | 2.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.3 | 1.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.3 | 1.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.3 | 2.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.3 | 1.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.3 | 4.3 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.3 | 1.2 | GO:0004802 | transketolase activity(GO:0004802) |
| 0.3 | 0.8 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.3 | 0.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.3 | 5.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.3 | 2.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.3 | 1.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.3 | 1.0 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.2 | 1.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.2 | 1.7 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.2 | 1.7 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.2 | 6.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.2 | 2.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.2 | 1.0 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.2 | 2.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.2 | 2.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.2 | 1.4 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.2 | 2.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 0.2 | 2.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.2 | 0.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.2 | 1.7 | GO:0005497 | androgen binding(GO:0005497) |
| 0.2 | 1.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.2 | 0.9 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.2 | 2.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.2 | 0.6 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.2 | 1.2 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.2 | 3.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.2 | 1.8 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.2 | 2.0 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.2 | 1.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 0.2 | 3.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.2 | 0.6 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.2 | 6.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.2 | 0.6 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.2 | 2.7 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.2 | 0.6 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.2 | 1.9 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.2 | 1.1 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.2 | 6.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.2 | 1.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.2 | 4.6 | GO:0031005 | filamin binding(GO:0031005) |
| 0.2 | 1.9 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.2 | 57.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.2 | 3.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.2 | 1.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.2 | 0.5 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.2 | 1.0 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.2 | 0.5 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
| 0.2 | 1.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.2 | 7.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.2 | 2.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.2 | 1.1 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.2 | 0.8 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.2 | 1.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.2 | 2.8 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.2 | 0.5 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 0.2 | 0.5 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
| 0.2 | 0.5 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.2 | 0.5 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 0.2 | 1.5 | GO:0005496 | steroid binding(GO:0005496) |
| 0.2 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.2 | 4.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.2 | 1.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 1.5 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.1 | 0.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 0.6 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 0.1 | 1.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 0.6 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
| 0.1 | 1.0 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.1 | 0.4 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.1 | 3.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 0.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.1 | 1.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.1 | 0.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.1 | 0.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.1 | 0.4 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.1 | 0.4 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.1 | 1.2 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.1 | 1.7 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.1 | 1.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.1 | 0.5 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.1 | 1.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.1 | 0.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.1 | 11.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 2.7 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.1 | 3.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 5.2 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 3.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.1 | 0.8 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.1 | 2.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 1.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.1 | 0.4 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.1 | 1.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.1 | 0.8 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.1 | 0.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 1.4 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.1 | 0.3 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.1 | 1.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.1 | 1.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.1 | 3.3 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.1 | 3.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.1 | 0.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.1 | 0.4 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.1 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.1 | 1.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 1.0 | GO:0071253 | connexin binding(GO:0071253) |
| 0.1 | 0.6 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.1 | 1.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.1 | 3.8 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.1 | 1.6 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.1 | 3.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 0.3 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.1 | 1.7 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.1 | 0.5 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
| 0.1 | 0.4 | GO:0031432 | titin binding(GO:0031432) |
| 0.1 | 0.4 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 0.1 | 0.6 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.1 | 1.4 | GO:0048185 | activin binding(GO:0048185) |
| 0.1 | 1.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 0.6 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 0.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.1 | 0.3 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.1 | 1.2 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
| 0.1 | 0.5 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.1 | 0.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.1 | 11.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 3.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.1 | 1.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.1 | 0.3 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.1 | 1.9 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.1 | 1.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.1 | 8.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 1.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.1 | 4.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.1 | 0.4 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.1 | 0.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.1 | 0.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 0.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 2.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.1 | 0.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.1 | 0.4 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.1 | 0.6 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.1 | 0.6 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 0.6 | GO:0035473 | lipase binding(GO:0035473) |
| 0.1 | 0.5 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.1 | 2.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 0.9 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
| 0.1 | 1.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.1 | 0.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.1 | 0.9 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.1 | 0.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.1 | 2.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.1 | 5.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.1 | 1.2 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 1.6 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.1 | 1.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 1.2 | GO:0016918 | retinal binding(GO:0016918) |
| 0.1 | 0.4 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.1 | 0.5 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.1 | 0.7 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.1 | 2.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 0.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.1 | 0.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.1 | 1.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.1 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.1 | 0.6 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.1 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 0.1 | 0.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 0.1 | 1.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.1 | 0.2 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
| 0.1 | 0.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.1 | 0.9 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.1 | 1.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.1 | 0.7 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.1 | 0.3 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.1 | 0.5 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.1 | 1.4 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.1 | 4.1 | GO:0051219 | phosphoprotein binding(GO:0051219) |
| 0.1 | 0.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.1 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.1 | 2.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 1.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.1 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 1.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 0.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 0.9 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 0.6 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.1 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 1.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.1 | 0.8 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 0.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.1 | 1.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.1 | 9.1 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.1 | 0.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.1 | 1.1 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
| 0.1 | 0.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.1 | 1.7 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 1.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.1 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.1 | 0.9 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.1 | 0.3 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.1 | 0.5 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.1 | 0.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.1 | 1.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.1 | 1.5 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.1 | 0.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 1.5 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 0.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 0.1 | 0.5 | GO:0015288 | porin activity(GO:0015288) |
| 0.0 | 0.8 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.0 | 0.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.0 | 0.4 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.0 | 0.2 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.0 | 0.5 | GO:0035240 | dopamine binding(GO:0035240) |
| 0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.0 | 0.5 | GO:0048038 | quinone binding(GO:0048038) |
| 0.0 | 0.2 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.0 | 0.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.0 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.0 | 0.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.0 | 6.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 2.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.0 | 0.2 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.0 | 5.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.0 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.0 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.0 | 1.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.0 | 0.6 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.0 | 1.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.0 | 0.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.0 | 0.7 | GO:0005549 | odorant binding(GO:0005549) |
| 0.0 | 0.2 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.0 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 0.0 | 0.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.0 | 0.2 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.0 | 4.0 | GO:0002020 | protease binding(GO:0002020) |
| 0.0 | 0.9 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.0 | 0.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.0 | 1.1 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.0 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.0 | 1.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.0 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.0 | 2.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.0 | 0.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.0 | 14.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 0.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.0 | 0.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.0 | 0.7 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.0 | 0.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.0 | 1.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.0 | 0.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.0 | 1.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.0 | 0.2 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
| 0.0 | 0.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.0 | 0.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.0 | 0.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.0 | 3.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 2.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.0 | 0.9 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 0.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 1.8 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.0 | 0.8 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
| 0.0 | 1.8 | GO:0019003 | GDP binding(GO:0019003) |
| 0.0 | 0.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.0 | 0.2 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.0 | 0.1 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
| 0.0 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.0 | 0.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.0 | 1.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.0 | 0.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.0 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.0 | 0.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.0 | 0.4 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.0 | 0.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.0 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.0 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.0 | 0.6 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.0 | 0.8 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.0 | 4.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.0 | 0.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.0 | 0.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.0 | 0.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 0.0 | 0.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.0 | 1.6 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.0 | 0.5 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 0.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.0 | 0.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.0 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.0 | 0.8 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.0 | 2.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.0 | 1.5 | GO:0005126 | cytokine receptor binding(GO:0005126) |
| 0.0 | 0.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.0 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 0.2 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.0 | 0.4 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.0 | 0.3 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.0 | 0.1 | GO:0004540 | ribonuclease activity(GO:0004540) |
| 0.0 | 0.4 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.0 | 0.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.0 | 0.7 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.0 | 1.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.0 | 0.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.0 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.0 | 0.5 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.0 | 0.4 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.0 | 0.5 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.0 | 1.8 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.0 | 0.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.0 | 0.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.0 | 0.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.0 | 1.7 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 3.2 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.0 | 0.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.0 | 0.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.0 | 0.0 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.0 | 0.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.0 | 0.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.0 | 0.4 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 0.5 | GO:0001653 | peptide receptor activity(GO:0001653) G-protein coupled peptide receptor activity(GO:0008528) |
| 0.0 | 0.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.0 | 0.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.0 | 0.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 9.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.4 | 10.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.4 | 27.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.3 | 12.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.3 | 20.3 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.2 | 10.9 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.2 | 11.9 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.2 | 6.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.2 | 1.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.2 | 4.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.2 | 1.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.2 | 4.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 5.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 6.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 7.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 37.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 1.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 3.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.1 | 2.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 4.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 0.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.1 | 3.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 2.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 1.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 3.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.1 | 5.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 3.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 1.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 2.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 1.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 2.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 3.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 4.5 | PID FOXO PATHWAY | FoxO family signaling |
| 0.1 | 3.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 3.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 3.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 1.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.1 | 2.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 4.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.1 | 2.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 0.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 2.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 1.8 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 2.1 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.1 | 4.8 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 1.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 0.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 3.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.1 | 4.7 | PID E2F PATHWAY | E2F transcription factor network |
| 0.1 | 1.0 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.1 | 2.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.1 | 2.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.1 | 0.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 0.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.0 | 0.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.0 | 1.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.0 | 1.8 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 0.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 2.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 0.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.0 | 1.2 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 9.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 0.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.0 | 1.0 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.0 | 1.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 0.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 0.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 0.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 0.4 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.0 | 0.5 | PID ATM PATHWAY | ATM pathway |
| 0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 0.5 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.0 | 0.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.0 | 0.2 | ST ADRENERGIC | Adrenergic Pathway |
| 0.0 | 0.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 14.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.6 | 10.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.5 | 4.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.4 | 2.0 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.4 | 14.0 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.3 | 9.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.3 | 3.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.2 | 5.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.2 | 3.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.2 | 6.8 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.2 | 6.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.2 | 3.5 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.2 | 8.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.2 | 3.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.2 | 4.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.2 | 2.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.2 | 2.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.2 | 2.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.2 | 0.9 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.2 | 8.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.2 | 6.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.2 | 4.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.2 | 2.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.2 | 9.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 4.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 2.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.1 | 14.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.1 | 1.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.1 | 7.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 2.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 2.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.1 | 1.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.1 | 2.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.1 | 5.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 1.9 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 0.1 | 2.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.1 | 1.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.1 | 1.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 3.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 2.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.1 | 1.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.1 | 4.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.1 | 1.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 4.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.1 | 3.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.1 | 1.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.1 | 1.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.1 | 2.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 1.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 0.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.1 | 2.8 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.1 | 1.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 1.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 9.6 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.1 | 3.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 1.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 3.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 0.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.1 | 4.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 3.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.1 | 4.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.1 | 0.8 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.1 | 1.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 1.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.1 | 1.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.1 | 1.5 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.1 | 2.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 4.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 0.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.1 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.1 | 0.5 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
| 0.1 | 0.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.1 | 1.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.1 | 7.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.1 | 1.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.1 | 3.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 0.5 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.1 | 1.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.0 | 2.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.0 | 1.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.0 | 1.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.0 | 1.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.0 | 2.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 2.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.0 | 0.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.0 | 1.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.0 | 0.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.0 | 1.0 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
| 0.0 | 6.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.0 | 0.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.0 | 0.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.0 | 0.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.0 | 0.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.0 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.0 | 2.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.0 | 0.3 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
| 0.0 | 1.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.0 | 0.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.0 | 2.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.0 | 1.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 0.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.0 | 0.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 0.5 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.0 | 0.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.0 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.0 | 2.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 2.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.0 | 0.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.0 | 0.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.0 | 0.9 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
| 0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.0 | 0.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.0 | 0.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.0 | 0.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 0.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 1.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.0 | 0.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.0 | 1.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 0.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 0.5 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.0 | 0.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.0 | 0.4 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
| 0.0 | 0.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.0 | 1.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 0.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.0 | 0.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.0 | 0.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.0 | 0.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.0 | 0.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.0 | 0.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 0.7 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |